Literature DB >> 22190082

Perspective: The clinical trial barriers.

Liang Liu1, Elaine Lai-Han Leung, Xiaoying Tian.   

Abstract

Mesh：

Year:  2011        PMID： 22190082     DOI： 10.1038/480S100a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine.

Authors:  Jan van der Greef; Herman van Wietmarschen; Jan Schroën; Mei Wang; Thomas Hankemeier; Guowang Xu
Journal:  Planta Med       Date:  2010-10-26       Impact factor: 3.352

2.  From genomic landscapes to personalized cancer management-is there a roadmap?

Authors:  Charles Swanton; Carlos Caldas
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

3.  Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients.

Authors:  Herman van Wietmarschen; Kailong Yuan; Cheng Lu; Peng Gao; Jiangshan Wang; Cheng Xiao; Xiaoping Yan; Mei Wang; Jan Schroën; Aiping Lu; Guowang Xu; Jan van der Greef
Journal:  J Clin Rheumatol       Date:  2009-10       Impact factor: 3.517

Review 4.  Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine.

Authors:  Felix W Frueh
Journal:  Pharmacogenomics       Date:  2009-07       Impact factor: 2.533

5.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

6.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

7.  Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.

Authors:  Jean-Yves Douillard; Frances A Shepherd; Vera Hirsh; Tony Mok; Mark A Socinski; Radj Gervais; Mei-Lin Liao; Helge Bischoff; Martin Reck; Mark V Sellers; Claire L Watkins; Georgina Speake; Alison A Armour; Edward S Kim
Journal:  J Clin Oncol       Date:  2009-12-28       Impact factor: 44.544
  7 in total
  13 in total

Review 1.  What has been overlooked on study of Chinese materia medica in the West?

Authors:  Willow J H Liu
Journal:  Chin J Integr Med       Date:  2015-07-09       Impact factor: 1.978

2.  Network-based drug discovery by integrating systems biology and computational technologies.

Authors:  Elaine L Leung; Zhi-Wei Cao; Zhi-Hong Jiang; Hua Zhou; Liang Liu
Journal:  Brief Bioinform       Date:  2012-08-09       Impact factor: 11.622

3.  Xiaoqinglong granules as add-on therapy for asthma: latent class analysis of symptom predictors of response.

Authors:  Qinglin Zha; Seqi Lin; Chi Zhang; Christopher Chang; Hanrong Xue; Cheng Lu; Miao Jiang; Yan Liu; Zuke Xiao; Weiyou Liu; Yunfei Shang; Jianjian Chen; Minyong Wen; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-03       Impact factor: 2.629

Review 4.  Building an Evidence-Base for TCM and Integrative East-West Medicine: A Review of Recent Developments in Innovative Research Design.

Authors:  Sonya Pritzker; Ka Kit Hui
Journal:  J Tradit Complement Med       Date:  2012-07

Review 5.  Wrist-ankle acupuncture for the treatment of pain symptoms: a systematic review and meta-analysis.

Authors:  Li Bing Zhu; Wai Chung Chan; Kwai Ching Lo; Tin Pui Yum; Lei Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-15       Impact factor: 2.629

6.  Is yangxue qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension?

Authors:  Jie Wang; Xiaochen Yang; Bo Feng; Weidong Qian; Zhuyuan Fang; Wei Liu; Haixia Li; Xiaoke Li; Fuyong Chu; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-21       Impact factor: 2.629

7.  Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials.

Authors:  Jie Wang; Bo Feng; Xiaochen Yang; Wei Liu; Yongmei Liu; Yun Zhang; Gui Yu; Shengjie Li; Yuqing Zhang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-24       Impact factor: 2.629

8.  Trends in the treatment of hypertension from the perspective of traditional chinese medicine.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Fuyong Chu; Pengqian Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-26       Impact factor: 2.629

9.  Chinese herbal medicine qi ju di huang wan for the treatment of essential hypertension: a systematic review of randomized controlled trials.

Authors:  Jie Wang; Xingjiang Xiong; Guoyan Yang; Yuqing Zhang; Yongmei Liu; Yun Zhang; Zhenpeng Zhang; Jun Li; Xiaochen Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-25       Impact factor: 2.629

Review 10.  Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients.

Authors:  Jie Wang; Xingjiang Xiong; Wei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-10       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.